Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
InChi: InChI=1S/C14H12O5/c1-7-6-9(15)10-11(16-2)8-4-5-18-12(8)14(17-3)13(10)19-7/h4-6H
17-pentamethyl-2
1-5H3/t14-/m0/s1
CYP17 inhibitor VT-464 selectively inhibits the enzymatic activity of the cytochrome P450 C17
Motesanib treatment also induces significant dose-dependent reductions in tumor growth and blood vessel density of MCF-7
N-acetyl-2-carboxy Benzenesulfonamide 10766 InChi: InChI=1S/C14H12O5/c1-7-6-9(15)10-11(16-2)8-4-5-18-12(8)14(17-3)13(10)19-7/h4-6HIC50: 0. 06 and 0. 25 M for COX 1 and COX 2, respectively N acetyl 2 carboxy Benzenesulfonamide is a non selective inhibitor of COX. Pharmaceutical inhibition of COX is able to provide relief from the symptoms of inflammation and pain. Nonsteroidal anti inflammatory drugs, such as aspirin, exert its effect via inhibition of COX. In vitro: Previous in vitro COX 1 COX 2 inhibition studies showed that N acetyl 2 carboxy benzenesulfonamide was a more
US$ 724.50
US$ 2724.50
US$ 1714.00
US$ 1499.50
US$ 13.45
US$ 3521.50
US$ 1599.50